Scientific Panel Urges FDA to Redo its Risk Assessment of BPA
Published: 12 November 2008
Category: Bisphenol A (BPA), Packaging CONCERNS, Studies/State & Federal Regulations
The “Washington Post” reports a Science Board advisory panel ruled that the Food and Drug Administration (FDA) made mistakes when determining that bisphenol A (BPA) was harmless and the agency should redo its risk assessment. The FDA’s position that BPA is safe has reportedly been controversial because it is out of step with more than 100 studies as well as a finding by the National Toxicology Program, part of the National Institutes of Health, that there is “some concern” that BPA may affect the brain and behavioral development in fetuses, infants and small children. FDA officials reportedly relied heavily on two studies funded by the American Plastics Council, which represents BPA manufacturers, in their evaluation of the chemical’s risks.